|
| 產(chǎn)地 | France |
| 品牌 | AntibodySystem |
| 保存條件 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term. |
| 貨號 | DHB95603 |
| 用途 | 僅用于科研 |
| 應(yīng)用范圍 | Research Grade Biosimilar |
| 抗原來源 | N/A |
| 保質(zhì)期 | 1 year |
| 抗體名 | Research Grade Rilonacept |
| 是否單克隆 | 是 |
| 克隆性 | |
| 靶點(diǎn) | |
| 適應(yīng)物種 | Human |
| 形態(tài) | Liquid |
| 宿主 | |
| 標(biāo)記物 | Unconjugate |
| 包裝規(guī)格 | 100 μg |
| 亞型 | Fusion - [IL1RAP (interleukin-1 receptor accessory protein) - IL1R1 (type 1 interleukin-1 receptor, interleukin 1 receptor, type I)]2 - IGHG1 Fc (Fragment constant) |
| 標(biāo)識物 | |
| 濃度 | % |
| 免疫原 | N/A |
| 是否進(jìn)口 | 是 |
Aiming to develop the most reliable bioreagents, AntibodySystem SAS was founded in 2019 in France by a team of professionals from top industrial companies and research institutes. The collective scientific and technical experiences in our team have brought breaking throughs in multiple product developments, including recombinant antibodies, recombinant proteins, biosimilar, RUO ELISA kits and other related products. By working with talented researchers and technicians, AntibodySystem continues to upgrade product qualities and lower the overall cost, offering accountable and affordable solutions for biolabs all over the world. Since its establishment, AntibodySystem has built long term and stable collaborations with academia, pharmaceutical industry, biotech companies and research hospitals, supporting their R&D by AntibodySystem's bioreagents with excellent data accuracy and reproducibility.
AntibodySystem由具有30多年蛋白抗體開發(fā)經(jīng)驗(yàn)的專家創(chuàng)立于法國,專注于生命科學(xué)和生物制藥領(lǐng)域研究,總部位于法國斯特拉斯堡市。AntibodySystem自主開發(fā)了高效、高產(chǎn)的真核重組表達(dá)系統(tǒng),利用該系統(tǒng)生產(chǎn)了高質(zhì)量的重組蛋白、抗體產(chǎn)品。目前產(chǎn)品包括藥物靶點(diǎn)蛋白以及對照抗體藥物、Invivo功能性抗體、SAA系列流式抗體、PEG抗體、磷酸化抗體、抗小分子抗體、ADA抗體、PK&ADA ELISA試劑盒。
如果您對我們的產(chǎn)品感興趣,請聯(lián)系027-65279366或17736698252(同微信)
以上產(chǎn)品僅用于科研,產(chǎn)品信息以產(chǎn)品說明書為準(zhǔn)
